Ping An Biomedical Co Ltd risk profile
95 Acute at or past the historical limit
Measured 1 September 2026 from PASW's filed statements. Recomputed nightly.
95 (Acute), driven by Competitive position at 100, over 3 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 85 | Acute | Volatile | One-year price volatility — 129.0% |
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | Reads operating_cashflow, capital_expenditure, free_cashflow, net_income and revenue. No reading is stored for this company. | |||
| Leverage and coverage | 85 | Acute | Easing | Net debt to EBITDA |
| Competitive position | 100 | Acute | Stable | Operating-margin gap against peers — -41.1 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Consumer Cyclical companies with a risk reading
Tesla Inc 48Home Depot Inc 46Alibaba Group Holding Ltd 65LVMH Moët Hennessy - Louis Vuitton Société Européenne 41Toyota Motor Corporation 46McDonald`s Corp 31Booking Holdings Inc 22TJX Companies Inc 36Fast Retailing Co., Ltd. 29Starbucks Corp 49PDD Holdings Inc 44Lowe`s Cos. Inc 49
Financials, valuation and price history for Ping An Biomedical Co Ltd